One patient each from the anti-HMGCR, anti-SRP, anti-PL-7, anti-EJ, and anti-MDA5 groups had cancer-IIM intervals of 1.33, 8.0, 6.0, 5.0, and 22.33 years, respectively (Fig. 3). This evidence concerns the gene HMGCR and cancer.